K. Valliant-Saunders

Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progression.

Chris P. Miller, C. A. Blau, K. Valliant-Saunders, 2010, Translational oncology.

Evaluating Erythropoietin‐Associated Tumor Progression Using Archival Tissues from a Phase III Clinical Trial

Chris P. Miller, N. Urban, C. A. Blau, 2009, Stem cells.

Stoichiometric oxidations of σ-bonds : Radical and possible non-radical pathways

E. Davidson, T. Matsuo, J. Mayer, 2006 .

Oxidation of tertiary silanes by osmium tetroxide.

D. Hrovat, W. T. Borden, E. Gunn, 2007, Inorganic chemistry.

Expanding the scope of WT1- and cyclin A1-specific TCR gene therapy for AML and other cancers

P. Greenberg, R. Perret, K. Valliant-Saunders, 2016 .

Paradoxically Increased FOXP3+ T Cells in IBD Do Not Preferentially Express the Isoform of FOXP3 Lacking Exon 2

S. Ziegler, R. Thirlby, H. Hahn, 2012, Digestive Diseases and Sciences.

Evaluating Erythropoietin‐Associated Tumor Progression Using Archival Tissues from a Phase III Clinical Trial

Chris P. Miller, N. Urban, M. Henke, 2009, Stem cells.